BioMarin Pharmaceutical Inc.

XTRA:BM8 주식 보고서

시가총액: €15.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

BioMarin Pharmaceutical 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

XTRA:BM8 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
06 Mar 24Sell€157,980Jean-Jacques BienaimeIndividual2,000€79.54
05 Mar 24Sell€2,770,166Henry FuchsIndividual35,341€78.38
27 Feb 24Sell€83,258Jean-Jacques BienaimeIndividual1,000€83.26
10 Aug 23Sell€985,064Henry FuchsIndividual12,000€82.09
09 Aug 23Sell€455,500C. GuyerIndividual5,360€84.98
08 Aug 23Sell€898,575George DavisIndividual11,000€81.69
08 Aug 23Sell€805,835Jean-Jacques BienaimeIndividual10,000€80.65

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.


소유권 분석

BM8 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업3,4980.00183%
주 또는 정부104,0830.0543%
개인 내부자1,372,5540.716%
교육기관190,143,24599.2%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.


최대 주주

상위 25 주주가 회사의 71.92%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
9.78%
PRIMECAP Management Company
18,414,374€1.5b0.04%1.21%
9.58%
The Vanguard Group, Inc.
18,050,062€1.5b1.97%0.03%
7.79%
BlackRock, Inc.
14,681,644€1.2b0.51%0.02%
7.43%
Dodge & Cox
13,994,063€1.1b-1.13%0.59%
5.72%
Capital Research and Management Company
10,774,641€883.4m79%0.05%
3.57%
State Street Global Advisors, Inc.
6,730,515€551.8m4.21%0.03%
2.88%
Columbia Management Investment Advisers, LLC
5,419,366€444.3m4.95%0.12%
2.74%
Barclays PLC Private Banking & Investment Banking Investment
5,159,429€423.0m5.3%0.32%
2.6%
Viking Global Investors LP
4,889,454€400.9m16%1.56%
2.28%
Avoro Capital Advisors LLC
4,300,000€352.5m11.7%4.96%
1.8%
Deutsche Asset & Wealth Management
3,384,512€277.5m145%0.16%
1.78%
Norges Bank Investment Management
3,361,310€275.6m22.1%0.03%
1.59%
Elliott Management Corporation
3,000,338€246.0m0%2.4%
1.52%
Geode Capital Management, LLC
2,872,432€235.5m3.98%0.02%
1.48%
Janus Henderson Group plc
2,790,343€228.8m-18.5%0.11%
1.35%
BNY Mellon Asset Management
2,541,990€208.4m6.94%0.04%
1.13%
Nomura Holdings Inc, Securities & Investment Arm
2,132,937€174.9m-24.9%0.97%
1.1%
JP Morgan Asset Management
2,071,088€169.8m-9.27%0.02%
0.98%
Parnassus Investments, LLC
1,849,348€151.6m-20.9%0.35%
0.85%
T. Rowe Price Group, Inc.
1,605,983€131.7m33.3%0.01%
0.83%
OrbiMed Advisors LLC
1,571,410€128.8m-2.71%1.93%
0.83%
Managed Account Advisors LLC
1,563,081€128.1m-0.08%0.03%
0.8%
Palo Alto Investors LP
1,500,749€123.0m-18%12.97%
0.76%
Pictet Asset Management Limited
1,436,723€117.8m-26%0.09%
0.73%
Charles Schwab Investment Management, Inc.
1,378,897€113.0m5.68%0.02%